Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,596,995
-
Share change
-
+14,392,994
-
Total reported value
-
$8,041,768
-
Put/Call ratio
-
3.7%
-
Price per share
-
$0.17
-
Number of holders
-
44
-
Value change
-
-$5,167,205
-
Number of buys
-
12
-
Number of sells
-
34
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q2 2023
As of 30 Jun 2023,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,596,995 shares.
The largest 10 holders included
BVF INC/IL, Lynx1 Capital Management LP, Octagon Capital Advisors LP, Aquilo Capital Management, LLC, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.